Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart

Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis

(2008) P H Sugden et al.   BRITISH JOURNAL OF PHARMACOLOGY

Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse

(2008) Yasuhiro Nishino et al.   CIRCULATION RESEARCH

Are transgenic mice the ‘alkahest’ to understanding myocardial hypertrophy and failure?

(2008) Stuart A. Cook et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: A role for ER stress?

(2008) Alexandra R. Cook et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Distinct roles of GSK-3  and GSK-3  phosphorylation in the heart under pressure overload

(2008) T. Matsuda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glycogen synthase kinases 3α and 3β in cardiac myocytes: Regulation and consequences of their inhibition

(2007) Thomais Markou et al.   CELLULAR SIGNALLING